Bath & Body Works (NYSE:BBWI) Updates Q2 2026 Earnings Guidance

Bath & Body Works (NYSE:BBWIGet Free Report) issued an update on its second quarter 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 0.300-0.300 for the period, compared to the consensus earnings per share estimate of 0.200. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion. Bath & Body Works also updated its FY 2026 guidance to 2.400-2.650 EPS.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a research report on Monday, April 20th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Bath & Body Works from $21.00 to $22.00 and gave the company a “hold” rating in a report on Tuesday, March 3rd. Citigroup cut shares of Bath & Body Works from a “buy” rating to a “neutral” rating and raised their price target for the company from $21.00 to $25.00 in a report on Tuesday, February 17th. Barclays raised their price target on shares of Bath & Body Works from $20.00 to $21.00 and gave the company an “equal weight” rating in a report on Monday, March 2nd. Finally, TD Cowen lowered their price target on shares of Bath & Body Works from $26.00 to $20.00 and set a “buy” rating on the stock in a report on Monday, May 18th. Three equities research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $21.21.

View Our Latest Stock Report on Bath & Body Works

Bath & Body Works Stock Performance

Shares of NYSE BBWI opened at $17.78 on Wednesday. The company has a market cap of $3.58 billion, a PE ratio of 5.64, a P/E/G ratio of 1.77 and a beta of 1.43. The business has a 50-day simple moving average of $18.67 and a two-hundred day simple moving average of $20.26. Bath & Body Works has a fifty-two week low of $14.27 and a fifty-two week high of $33.96.

Bath & Body Works (NYSE:BBWIGet Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, sell-side analysts predict that Bath & Body Works will post 2.61 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 19th. Shareholders of record on Friday, June 5th will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, June 5th. This represents a $0.80 dividend on an annualized basis and a yield of 4.5%. Bath & Body Works’s dividend payout ratio (DPR) is currently 25.40%.

Hedge Funds Weigh In On Bath & Body Works

Institutional investors have recently bought and sold shares of the business. Geneos Wealth Management Inc. raised its position in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after buying an additional 801 shares during the last quarter. Danske Bank A S purchased a new position in Bath & Body Works during the 3rd quarter worth approximately $39,000. Global Retirement Partners LLC purchased a new position in Bath & Body Works during the 4th quarter worth approximately $31,000. Advisory Services Network LLC purchased a new position in Bath & Body Works during the 3rd quarter worth approximately $48,000. Finally, Parallel Advisors LLC raised its position in Bath & Body Works by 42.6% during the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after buying an additional 567 shares during the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

About Bath & Body Works

(Get Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Read More

Earnings History and Estimates for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.